ArticleNature communications2025

Liver-specific paraoxonase-1 alleviates regulatory T cell-driven immunosuppression via metabolic reprogramming in hepatocellular carcinoma.

Zhou Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.